Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionAmerican Century Companies Inc
Latest Disclosed Ownership23,814 shares
Latest Disclosed Value $ 707,514
American Century Companies Inc ownership in TVTX / Travere Therapeutics, Inc.

On May 15, 2026 - American Century Companies Inc filed a 13F-HR form disclosing ownership of 23,814 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $707,514 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 2, 2018 disclosing 0 shares of Travere Therapeutics, Inc.. The current value of the position is $1,076,393 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 23,814 23,814 708 0.0004
2018-11-02 2018-09-30 13F RETROPHIN COM 761299106 0 -97,702 -100.00 0 -100.00
2018-08-08 2018-06-30 13F RETROPHIN COM 761299106 97,702 -179,788 -64.79 2,663 -57.08 0.0027
2018-05-03 2018-03-31 13F RETROPHIN COM 761299106 277,490 399 0.14 6,205 6.29 0.0063
2018-02-02 2017-12-31 13F RETROPHIN COM 761299106 277,091 -8,784 -3.07 5,838 -17.95 0.0058
2017-11-01 2017-09-30 13F RETROPHIN COM 761299106 285,875 134,205 88.48 7,115 141.92 0.0072
2017-08-07 2017-06-30 13F RETROPHIN COM 761299106 151,670 44,969 42.14 2,941 49.29 0.0030
2017-05-02 2017-03-31 13F RETROPHIN COM 761299106 106,701 -53,781 -33.51 1,970 -35.15 0.0020
2017-02-03 2016-12-31 13F RETROPHIN COM 761299106 160,482 62,386 63.60 3,038 38.41 0.0033
2016-11-01 2016-09-30 13F RETROPHIN COM 761299106 98,096 98,096 2,195 0.0024
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.